Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-138-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-138-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, I too gladly supported this report, because, as my fellow Members have mentioned several times, WHO estimates indicate that falsified medicinal products are circulated in large quantities in EU Member States. Their number is continuously increasing, and we must therefore do everything in our power to prevent falsified medicines from entering the supply chain. Even though this does not threaten the entire pharmaceutical industry, it still undermines people’s confidence in pharmacies, not to mention the fact that falsified medicinal products may contain sub-standard active ingredients. Estimates indicate that the number of boxes of falsified medicines could reach 42 million by 2020, exposing the European economy to significant risk.
The European pharmaceutical sector realises a total annual turnover of more than EUR 170 billion. We must prevent unfair competition from foreign producers that place medicinal products on the market, the manufacturing process of which cannot be checked. Furthermore, I believe it is important that we discuss matters such as the sale of medicinal products over the Internet. Through virtual pharmacies, products which are clearly subject to medical prescription are available over the worldwide web. Not to mention that this is the easiest way for counterfeiters to introduce their products into the supply chain."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples